These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 26318388)

  • 41. Uric acid lowering therapy in cardiovascular diseases.
    Volterrani M; Iellamo F; Sposato B; Romeo F
    Int J Cardiol; 2016 Jun; 213():20-2. PubMed ID: 26386814
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Xanthine and uric acid levels in rat brain following focal ischemia.
    Kanemitsu H; Tamura A; Kirino T; Karasawa S; Sano K; Iwamoto T; Yoshiura M; Iriyama K
    J Neurochem; 1988 Dec; 51(6):1882-5. PubMed ID: 3183665
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Assessment of xanthine oxidase in human lung and lung transplantation.
    Kinnula VL; Sarnesto A; Heikkilä L; Toivonen H; Mattila S; Raivio KO
    Eur Respir J; 1997 Mar; 10(3):676-80. PubMed ID: 9073004
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lithospermic acid as a novel xanthine oxidase inhibitor has anti-inflammatory and hypouricemic effects in rats.
    Liu X; Chen R; Shang Y; Jiao B; Huang C
    Chem Biol Interact; 2008 Nov; 176(2-3):137-42. PubMed ID: 18694741
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Suppression of superoxide anion generation catalyzed by xanthine oxidase with alkyl caffeates and the scavenging activity.
    Masuoka N; Kubo I
    Int J Food Sci Nutr; 2016; 67(3):283-7. PubMed ID: 26940252
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Uric acid in CHF: marker or player in a metabolic disease?
    Doehner W; von Haehling S; Anker SD
    Int J Cardiol; 2007 Feb; 115(2):156-8. PubMed ID: 16844250
    [No Abstract]   [Full Text] [Related]  

  • 47. Changes in uric acid levels and allopurinol use in chronic heart failure: association with improved survival.
    Gotsman I; Keren A; Lotan C; Zwas DR
    J Card Fail; 2012 Sep; 18(9):694-701. PubMed ID: 22939038
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The relationship between hypertension and plasma allantoin, uric acid, xanthine oxidase activity and nitrite, and their predictive capacity in severe preeclampsia.
    Elmas O; Elmas O; Aliciguzel Y; Simsek T
    J Obstet Gynaecol; 2016; 36(1):34-8. PubMed ID: 26366935
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dispelling dogma and misconceptions regarding the most pharmacologically targetable source of reactive species in inflammatory disease, xanthine oxidoreductase.
    Kelley EE
    Arch Toxicol; 2015 Aug; 89(8):1193-207. PubMed ID: 25995007
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sildenafil protects epithelial cell through the inhibition of xanthine oxidase and the impairment of ROS production.
    Taibi G; Carruba G; Miceli V; Cocciadiferro L; Cucchiara A; Nicotra CM
    Free Radic Res; 2010 Feb; 44(2):232-9. PubMed ID: 19968586
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hyperuricaemia predicts poor outcome in patients with mild to moderate chronic heart failure.
    Jankowska EA; Ponikowska B; Majda J; Zymlinski R; Trzaska M; Reczuch K; Borodulin-Nadzieja L; Banasiak W; Ponikowski P
    Int J Cardiol; 2007 Feb; 115(2):151-5. PubMed ID: 16782216
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relationships among hyperuricemia, endothelial dysfunction and cardiovascular disease: molecular mechanisms and clinical implications.
    Puddu P; Puddu GM; Cravero E; Vizioli L; Muscari A
    J Cardiol; 2012 May; 59(3):235-42. PubMed ID: 22398104
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Is there a role for uric acid in an animal model of calcium phosphate nephrocalcinosis and calcium phosphate crystallization in urine of patients with idiopathic calcium urolithiasis? An orientational study.
    Schwille PO; Schmiedl A; Manoharan M; Wipplinger J
    J Endourol; 1999 Nov; 13(9):637-45. PubMed ID: 10608515
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The treatment of hyperuricemia.
    Gliozzi M; Malara N; Muscoli S; Mollace V
    Int J Cardiol; 2016 Jun; 213():23-7. PubMed ID: 26320372
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Xanthine oxidase binding to glycosaminoglycans: kinetics and superoxide dismutase interactions of immobilized xanthine oxidase-heparin complexes.
    Radi R; Rubbo H; Bush K; Freeman BA
    Arch Biochem Biophys; 1997 Mar; 339(1):125-35. PubMed ID: 9056242
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Physiologic levels of uric acid inhibit xanthine oxidase in human plasma.
    Tan S; Radi R; Gaudier F; Evans RA; Rivera A; Kirk KA; Parks DA
    Pediatr Res; 1993 Sep; 34(3):303-7. PubMed ID: 8134172
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Metabonomics revealed xanthine oxidase-induced oxidative stress and inflammation in the pathogenesis of diabetic nephropathy.
    Liu J; Wang C; Liu F; Lu Y; Cheng J
    Anal Bioanal Chem; 2015 Mar; 407(9):2569-79. PubMed ID: 25636229
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Uric acid in cachectic and noncachectic patients with chronic heart failure: relationship to leg vascular resistance.
    Doehner W; Rauchhaus M; Florea VG; Sharma R; Bolger AP; Davos CH; Coats AJ; Anker SD
    Am Heart J; 2001 May; 141(5):792-9. PubMed ID: 11320368
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vitro differential metabolism of merbarone by xanthine oxidase and microsomal flavoenzymes. The role of reactive oxygen species.
    Muindi JF; Stevens YW; Warrell RP; Young CW
    Drug Metab Dispos; 1993; 21(3):410-4. PubMed ID: 8100495
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hyperuricemia and cardiovascular disease risk.
    Borghi C; Verardi FM; Pareo I; Bentivenga C; Cicero AF
    Expert Rev Cardiovasc Ther; 2014 Oct; 12(10):1219-25. PubMed ID: 25192804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.